REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re-pricing of Options

7 May 2010 07:00

RNS Number : 4898L
Cubus Lux plc
07 May 2010
 



7 May 2010

Cubus Lux plc

("Cubus Lux" or the "Company")

Re-pricing of Options

 

The Company currently has outstanding options over 867,500 ordinary shares, representing 4.6 per cent. of the Company's current issued share capital. These options were granted to directors and employees prior to the admission to trading on AIM of the Company's issued share capital in February 2008 pursuant to a share option scheme adopted on 27 April 2006. The outstanding options have exercise prices between £1.00 and £1.6275, compared to a mid market price, at close on the day preceding this announcement, of 15p. 767,500 of these options expire on 26 April 2011 with the remaining 100,000 expiring on 26 April 2012.

630,000 of these outstanding options are held by directors of the Company. As recognition of the work of the directors since admission, and in view of the low level of salaries currently charged by those directors, the Company has decided to reduce the exercise price on all the options to 15p, being the closing mid market price on the day immediately preceding this announcement. This will result in an additional charge in the income statement for current financial year of approximately £500,000.

The re-pricing of the options is deemed a related party transaction under the AIM Rules for Companies. Francisco Alvarez, being the only independent director, having consulted with Astaire Securities plc, as the Company's nominated adviser, considers that the terms of the transaction are fair and reasonable in so far as the Company's shareholders are concerned.

 

For further information about the Company please see www.cubuslux.com or contact:

Cubus Lux plc

Steve McCann

+44 (0) 7787 183 184

Astaire Securities plc (Nomad)

Antony Legge / Luke Cairns

+44 (0) 20 7448 4400

Hybridan LLP (Broker)

Claire Louise Noyce / Stephen Austin

+44 (0) 20 7947 4350

City Road Communications

Pam Spooner

+44 (0) 20 7248 8010

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFEEFIRIII
Date   Source Headline
23rd Dec 20227:00 amRNSTR-1: Standard notification of major holdings
23rd Dec 20227:00 amRNSCellular Goods Annual Results
23rd Nov 20226:16 pmRNSTR-1: Standard notification of major holdings
2nd Nov 202210:34 amRNSTR-1: Standard notification of major holdings
24th Oct 20227:00 amRNSProducts launch on Debenhams.com
20th Oct 20227:00 amRNSLaunch of gift set collection for festive season
26th Sep 20227:00 amRNSProposed purchase of Cannaray Brands and Love CBD
23rd Sep 20225:49 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:47 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20225:42 pmRNSTR-1: Standard notification of major holdings
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
23rd Sep 20227:00 amRNSCellular Goods now shipping products to the USA
21st Sep 20222:06 pmRNSSecond Price Monitoring Extn
21st Sep 20222:00 pmRNSPrice Monitoring Extension
21st Sep 20227:00 amRNSLaunch of three new skincare products
6th Sep 20227:00 amRNSPublication of new white paper
17th Aug 20227:00 amRNSGrant of Share Options
16th Aug 20227:00 amRNSAppointment of new Chief Financial Officer
5th Aug 20224:40 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
4th Aug 20229:05 amRNSSecond Price Monitoring Extn
4th Aug 20229:00 amRNSPrice Monitoring Extension
3rd Aug 20224:41 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
3rd Aug 20229:05 amRNSSecond Price Monitoring Extn
3rd Aug 20229:00 amRNSPrice Monitoring Extension
2nd Aug 20224:40 pmRNSSecond Price Monitoring Extn
2nd Aug 20224:35 pmRNSPrice Monitoring Extension
2nd Aug 202211:05 amRNSSecond Price Monitoring Extn
2nd Aug 202211:00 amRNSPrice Monitoring Extension
1st Aug 20222:00 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSUpdate on marketing initiatives and YouGov survey
11th Jul 20227:00 amRNSLaunch of minis
20th Jun 20227:00 amRNSLaunch of CBG and CBD petition
30th May 20227:00 amRNSInterim results
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
20th May 20227:00 amRNSTR-1: Standard notification of major holdings
16th May 20222:05 pmRNSSecond Price Monitoring Extn
16th May 20222:00 pmRNSPrice Monitoring Extension
12th May 20227:00 amRNSBoard changes
28th Apr 20227:00 amRNSInvestor presentation
28th Apr 20227:00 amRNSFirst patent application filed
22nd Apr 20226:04 pmRNSUpdate on ingestibles product range
22nd Apr 20227:00 amRNSWhite paper on lab-produced cannabinoids
13th Apr 20227:00 amRNSUpdate on ingestibles product range
11th Apr 20227:00 amRNSUpdate on ingestibles products
7th Apr 202210:24 amRNSTR-1: Standard notification of major holdings
1st Apr 20222:05 pmRNSSecond Price Monitoring Extn
1st Apr 20222:00 pmRNSPrice Monitoring Extension
28th Mar 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.